These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 37635282

  • 1. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.
    Transplantation; 2024 Mar 01; 108(3):713-723. PubMed ID: 37635282
    [Abstract] [Full Text] [Related]

  • 2. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S.
    Liver Transpl; 2021 Jul 01; 27(7):971-983. PubMed ID: 33492764
    [Abstract] [Full Text] [Related]

  • 3. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 4. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH, Kim DG, Kang M, Koh HH, Choi MC, Min EK, Lee JG, Kim MS, Joo DJ.
    Int J Surg; 2023 Nov 01; 109(11):3459-3466. PubMed ID: 37565633
    [Abstract] [Full Text] [Related]

  • 5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep 01; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 6. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C, Liu H, Zhang X, Ganoza A, Crane A, Powers C, Gunabushanam V, Behari J, Molinari M.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38837956
    [Abstract] [Full Text] [Related]

  • 7. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr 08; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 8. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 08; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 9. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May 08; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

  • 10. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.
    Transplantation; 2014 Feb 27; 97(4):457-62. PubMed ID: 24531822
    [Abstract] [Full Text] [Related]

  • 11. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA.
    JAMA Surg; 2022 Oct 01; 157(10):926-932. PubMed ID: 35921119
    [Abstract] [Full Text] [Related]

  • 12. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 01; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 13. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y.
    Liver Transpl; 2016 Dec 01; 22(12):1666-1675. PubMed ID: 27540888
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC, Fung JY, Pang HH, Leung CK, Li HF, Sin SL, Ma KW, She BW, Dai JW, Chan AC, Cheung TT, Lo CM.
    Hepatology; 2021 Jun 01; 73(6):2441-2454. PubMed ID: 33006772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS, Ruebner RL, Abt PL.
    Am J Transplant; 2015 Oct 01; 15(10):2732-8. PubMed ID: 25969133
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y, Wang Q, Yang J, Yan L.
    PLoS One; 2015 Oct 01; 10(9):e0136604. PubMed ID: 26378786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, Bhangui P, Soin AS.
    Clin Transplant; 2017 Aug 01; 31(8):. PubMed ID: 28497523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.